• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION BLAZER II HTD; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION BLAZER II HTD; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number 85056
Device Problem Temperature Problem (3022)
Patient Problem Swelling/ Edema (4577)
Event Date 07/16/2021
Event Type  Injury  
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
During an ablation procedure to treat supraventricular tachycardia a blazer ii htd catheter was selected for use.It was reported that the temperature did not meet the ablation requirements of the lesion.Repeated ablation attempts resulted in edema on the contact surface of the lesion."emergency treatment" might have been performed to treat the edema, however the details are unknown.The procedure was cancelled and rescheduled.No additional complications were reported and the patient's current condition is fine.
 
Manufacturer Narrative
The device was received by boston scientific for analysis.Upon product analysis it was observed that the continuity test was performed, and the device was found within specifications.No opens or shorts were found.The ablation was verified by using the maestro generator 4000, and the device was found within specifications.Based on the information provided, there is no evidence that the device was used in a manner inconsistent with the labelled indications/instructions for use (ifu).The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Event Description
During an ablation procedure to treat supraventricular tachycardia a blazer ii htd catheter was selected for use.It was reported that the temperature did not meet the ablation requirements of the lesion.Repeated ablation attempts resulted in edema on the contact surface of the lesion."emergency treatment" might have been performed to treat the edema, however the details are unknown.The procedure was cancelled and rescheduled.No additional complications were reported and the patient's current condition is fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLAZER II HTD
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key12590986
MDR Text Key275196376
Report Number2134265-2021-12346
Device Sequence Number1
Product Code LPB
UDI-Device Identifier08714729172048
UDI-Public08714729172048
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P920047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/21/2022
Device Model Number85056
Device Catalogue Number85056
Device Lot Number0023838648
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/07/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/16/2021
Initial Date FDA Received10/07/2021
Supplement Dates Manufacturer Received10/22/2021
Supplement Dates FDA Received11/10/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/22/2019
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient SexMale
Patient Weight60 KG
-
-